\
&
Contact us
\
&
Contact us
Starts in 2 weeks from now
LocationBrussels
The ECS Brokerage Event combines the brokerage activities of the industry associations AENEAS, EPoSS and INSIDE into one networking event dedicated to project proposals for the new Chips JU Calls 2026.
This event gathers the ECS community around project ideas, allowing it to network, build consortia and start creating project proposals.
More information and the possibility to register can be found on the event website.
Please note that this is a paying event.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
MSCA Research Infrastructures Health Culture and society Security
Health Climate, Energy, Mobility Agro-Food, Environment Missions
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
